L & L International Holdings Announces Third Quarter Results
Yesterday, L&L International Holdings (OTCBB: LLFH) released their 10Q for the third quarter and released news summarizing the quarter. Income grew by about 80% to $9.9 million and net income from continuing operations was $2.03 million or approximately 10 cents per share. For complete details read the 10Q. Look at footnote 19 for details of results of discontinued operations which was the sale of the LEK air compressor business.
For the 9 months ending 1/31/2009, results were $30.9 million in income from continuing operations (the coal business) and net income was up 581% to $7.36 million or .34 cents per share. A link to the release is below. At the current offer of $1.01 the stock is selling at roughly 3 times earnings for the first 3 quarters of the current fiscal year. LLFH is an undiscovered opportunity. It is a growing company with operations in China where over 70% of energy is generated with coal. In addition, the infrastructure is also growing and is fueling demand for the coking coal side of LLFH. Do your research on LLFH. Last week, Mark Hulbert, the investment newsletter monitor, stated that he felt micro cap and small cap stocks would offer potential for better returns than larger companies due to their ability to more rapidly adapt to changing conditions in the world's economy. Below are links to the news from yesterday and the company web site.
Link to Release
www.lnlinternational.com
Company Address
130 Andover Park East, Suite 101,Seattle, Washington 98188 USAPhone: (206) 264-8065Fax: (206) 264-7971http://www.lnlinternational.com/
Investor Relations
Jim PainterEmerging Markets Consulting, LLC.
126 S. Bumby Avenue, Suite A
Orlando, Florida 32803
Telephone: (321)206-6682
Website:www.emergingmarketsllc.comE-mail: jamespainter@emergingmarketsllc.com
Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation:
Disclaimer: EMC has a March 16, 2009 agreement with L & L International Holdings, Inc. (LLFH) to provide various services to LLFH for a 6 month period. The agreement may be renewed for additional 6 month or longer periods (Renewal Term) unless LLFH or EMC provide written notice of termination to the other party. The terms of the agreement provide that LLFH pay EMC 6,000 rule 144 shares per month. To date EMC has been compensated 6,000 rule 144 shares.
Click here for full disclaimer
Tuesday, March 24, 2009
Ronn Motor Company to Begin Field Training With Select AAMCO Dealers for the Installation of the Proprietary H2GO(TM) Hydrogen Injection System
Released Mar 24, 2009 -- Ronn Motor Company, Inc. (Other OTC:RNNM.PK - News) announced today it will begin training in April 2009 for installation procedures for its proprietary H2GO(TM) hydrogen injection system at select AAMCO transmission locations in the Houston, Austin, Ft. Worth, New Orleans and Phoenix areas. Ronn Motors will be working closely with Doug Watkins, owner of four Houston franchises, and other AAMCO owners and association members. Together, they will finalize installation procedures and packaging for its real-time H2GO(TM) hydrogen injection system.
Ronn Maxwell, CEO of Ronn Motors, stated, "This will initiate a rapid roll out of our H2GO(TM) system across the nation through Frigette Energy System's massive distribution network. We view this as the launching pad for H2GO(TM) to transcend the U.S., ultimately becoming a consumer must-have."
Doug Watkins, Owner of Drive Train Services Inc., a major franchisor of AAMCO Transmissions, commented, "AAMCO Transmissions currently has 915 locations nationwide with plans to open an additional 60 centers this year. While I cannot commit all 915 locations to installation, as we are individually owned and operated, I feel confident that working through the Owners Association, AAMCO could be one of the top performers in sales and installation for the H2GO(TM) systems."
Watkins continued, "It is our belief that based on a 2 hour installation time, we could have installations as high as 10 units per week assuming two units a day per store. If we estimate that a modest participation level of 50% of all stores, estimated sales and installations would approach 54,840 units per quarter. This is an estimate only and is based on several variables that have not been fully determined yet. If the H2GO(TM) system performs as expected, we think franchisor and public acceptance of the H2GO(TM) system will support these estimates and they may turn out to be conservative."
AAMCO Transmissions is in the transmission repair business. The company is a leading franchiser of transmission fix-it facilities with about 900 independently owned and operated shops throughout the US, Canada, and Puerto Rico. Along with transmission work, AAMCO stores provide automotive cooling and electrical system repairs, as well as other general maintenance services.
Headquartered in Horseshoe Bay, Texas, Ronn Motor Company, Inc. is a design and manufacturing company focused on the leading edge engineering of environmentally friendly, finely built premium automobiles and technology. These systems include Hydrogen Fuel, Fuel cells, and Plug in-electrics. These features, coupled with RMC's core values of a strong sense of ethics, environmental sensitivity and premium quality, positions the Company as one of the new leaders in an automotive industry transitioning toward fuel efficiency. For more information, please visit
This release contains forward-looking statements that reflect Ronn Motor plans and expectations. In this press release and related comments by Company management, words like "expect," "anticipate," "estimate," "forecast," "objective," "plan," "goal" and similar expressions are used to identify forward-looking statements, representing management's current judgment and expectations about possible future events. Management believes these forward-looking statements and the judgments upon which they are based to be reasonable, but they are not guarantees of future performance and involve numerous known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance, achievements or financial position to be materially different from any future results, performance, achievements or financial position expressed or implied by these forward-looking statements.
Image Available:
Contact:
Ronn Motors Investor Relations Contact:
The Eversull Group, Inc.Jack Eversull972-378-7917972-378-7981
(fax)
Investor Relations
Jim PainterEmerging Markets Consulting, LLC.
126 S. Bumby Avenue, Suite A
Orlando, Florida 32803
Telephone: (321)206-6682
Disclaimer: Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below:
EMC has a March 16th, 2009 agreement with Silverdust Investment corp. to provide various services onbehalf of Ronn Motor Corp. for a one (1) month period. The agreement will be renewed for one additional (1) month period ("Renewal Term"), unless EMC or Silverdust provide written notice of termination to the other party. The terms of the agreement provide that Silverdust will pay EMC the following compensation for its services: The sum of $7,500 per month. To Date 7500 dollars have been paid to EMC.
Released Mar 24, 2009 -- Ronn Motor Company, Inc. (Other OTC:RNNM.PK - News) announced today it will begin training in April 2009 for installation procedures for its proprietary H2GO(TM) hydrogen injection system at select AAMCO transmission locations in the Houston, Austin, Ft. Worth, New Orleans and Phoenix areas. Ronn Motors will be working closely with Doug Watkins, owner of four Houston franchises, and other AAMCO owners and association members. Together, they will finalize installation procedures and packaging for its real-time H2GO(TM) hydrogen injection system.
Ronn Maxwell, CEO of Ronn Motors, stated, "This will initiate a rapid roll out of our H2GO(TM) system across the nation through Frigette Energy System's massive distribution network. We view this as the launching pad for H2GO(TM) to transcend the U.S., ultimately becoming a consumer must-have."
Doug Watkins, Owner of Drive Train Services Inc., a major franchisor of AAMCO Transmissions, commented, "AAMCO Transmissions currently has 915 locations nationwide with plans to open an additional 60 centers this year. While I cannot commit all 915 locations to installation, as we are individually owned and operated, I feel confident that working through the Owners Association, AAMCO could be one of the top performers in sales and installation for the H2GO(TM) systems."
Watkins continued, "It is our belief that based on a 2 hour installation time, we could have installations as high as 10 units per week assuming two units a day per store. If we estimate that a modest participation level of 50% of all stores, estimated sales and installations would approach 54,840 units per quarter. This is an estimate only and is based on several variables that have not been fully determined yet. If the H2GO(TM) system performs as expected, we think franchisor and public acceptance of the H2GO(TM) system will support these estimates and they may turn out to be conservative."
AAMCO Transmissions is in the transmission repair business. The company is a leading franchiser of transmission fix-it facilities with about 900 independently owned and operated shops throughout the US, Canada, and Puerto Rico. Along with transmission work, AAMCO stores provide automotive cooling and electrical system repairs, as well as other general maintenance services.
Headquartered in Horseshoe Bay, Texas, Ronn Motor Company, Inc. is a design and manufacturing company focused on the leading edge engineering of environmentally friendly, finely built premium automobiles and technology. These systems include Hydrogen Fuel, Fuel cells, and Plug in-electrics. These features, coupled with RMC's core values of a strong sense of ethics, environmental sensitivity and premium quality, positions the Company as one of the new leaders in an automotive industry transitioning toward fuel efficiency. For more information, please visit
This release contains forward-looking statements that reflect Ronn Motor plans and expectations. In this press release and related comments by Company management, words like "expect," "anticipate," "estimate," "forecast," "objective," "plan," "goal" and similar expressions are used to identify forward-looking statements, representing management's current judgment and expectations about possible future events. Management believes these forward-looking statements and the judgments upon which they are based to be reasonable, but they are not guarantees of future performance and involve numerous known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance, achievements or financial position to be materially different from any future results, performance, achievements or financial position expressed or implied by these forward-looking statements.
Image Available:
Contact:
Ronn Motors Investor Relations Contact:
The Eversull Group, Inc.Jack Eversull972-378-7917972-378-7981
(fax)
Investor Relations
Jim PainterEmerging Markets Consulting, LLC.
126 S. Bumby Avenue, Suite A
Orlando, Florida 32803
Telephone: (321)206-6682
Disclaimer: Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below:
EMC has a March 16th, 2009 agreement with Silverdust Investment corp. to provide various services onbehalf of Ronn Motor Corp. for a one (1) month period. The agreement will be renewed for one additional (1) month period ("Renewal Term"), unless EMC or Silverdust provide written notice of termination to the other party. The terms of the agreement provide that Silverdust will pay EMC the following compensation for its services: The sum of $7,500 per month. To Date 7500 dollars have been paid to EMC.
Monday, March 16, 2009
Puradyn Develops Market in Nigeria With Oceanic Consultants Nigeria Ltd.
(OTCBB: PFTI)
Released Monday March 16, 5:30 am ET Bypass Oil Filtration Technology 'Perfect Fit' for This Promising Market
BOYNTON BEACH, FL--(MARKET WIRE)--Mar 16, 2009 -- Puradyn Filter Technologies Incorporated (OTC BB:PFTI.OB - News) today announced it has entered into an exclusive Sales Representative Agreement with Oceanic Consultants Nigeria Limited ("Oceanic") for the country of Nigeria and adjacent waters, effectively opening the market for the puraDYN® bypass oil filtration system.
Headquartered in Houston, Texas with offices in Lagos, Nigeria, Oceanic specializes in assisting local businesses provide services to the oil and gas exploration and production industry, and is a wholly owned subsidiary of CAMAC International, also headquartered in Houston.
Steven R. Hill, Senior Vice President and Project Manager, Oceanic, stated, "The drilling unit currently drilling for Allied Eni (a subsidiary of CAMAC) uses 6 diesel generators, each with a sump capacity of 165 gallons, 3 that operate 24/7, with 2 generators on standby and one which operates intermittently. Through use of Puradyn's microfiltration technology to keep oil continuously clean, we will be able to conservatively save 50% of lube oil purchase. Each oil change costs approximately $1,650 per generator every 6 weeks, and there are currently 67 mobile drilling units in Nigerian waters that would be potential candidates for this technology. These numbers do not factor the costs of transporting new oil to the rig and the handling and disposal of the used oil. We will be contacting all the rig contractors over the next 3-4 months."
Hill continued, "This technology will allow Oceanic to centrally stock and service this product from Lagos, Nigeria, thus maximizing local content and meeting regulatory requirements using Oceanic service support."
Hill concluded, "The potential market for the Puradyn system is substantial when the number of rigs, support vessels, trucks and other equipment are taken into account and we intend to apply similar systems to equipment used in the local construction and mining industries. Oceanic looks forward to being able to represent this product in Nigeria."
Joseph V. Vittoria, Puradyn's Chairman and CEO, said, "We expect initial start up sales to be slow as Oceanic educates the area market on the benefits of bypass oil filtration technology, but gain momentum quickly as the early benefits are recognized. If all 67 rigs use the Puradyn system, the potential savings in oil would be approximately 40,000 gallons of oil per scheduled oil change. Nigeria is a crucial player in oil production and exploration and we believe our new relationship with Oceanic, a company successfully operating in Nigeria, is a perfect fit."
About Puradyn Filter Technologies Incorporated
Puradyn (OTC BB:PFTI.OB - News) designs, manufactures and markets the puraDYN Oil Filtration System, the most effective bypass oil filtration product on the market today. It continuously cleans lubricating oil and maintains oil viscosity to safely and significantly extend oil change intervals and engine life. Effective for internal combustion engines, transmissions and hydraulic applications, the Company's patented and proprietary system is a cost-effective and energy-conscious solution targeting an annual $15 billion potential industry. puraDYN® equipment was selected as the manufacturer used by the US Department of Energy in a three-year evaluation to research and analyze the performance, benefits and cost analysis of bypass oil filtration technology.
STATEMENTS IN THIS PRESS RELEASE WHICH ARE NOT HISTORICAL DATA ARE FORWARD-LOOKING STATEMENTS WHICH INVOLVE KNOWN AND UNKNOWN RISKS, UNCERTAINTIES OR OTHER FACTORS NOT UNDER THE COMPANY'S CONTROL, INCLUDING BUT NOT LIMITED TO THE POSSIBLE INABILITY TO RAISE CAPITAL FUNDS, LACK OF PROTECTION FROM INTELLECTUAL PROPERTY, VULNERABILITY BECAUSE OF MANUFACTURING A LIMITED NUMBER OF PRODUCTS, DEPENDENCE ON DISTRIBUTORS, ORDERS PREVIOUSLY STATED IN THIS PRESS RELEASE MAY NOT MATERIALIZE, AND THE POSSIBILITY THAT THE PRODUCTS DO NOT MEET CUSTOMERS' NEEDS, WHICH MAY CAUSE ACTUAL RESULTS, PERFORMANCE OR ACHIEVEMENTS OF THE COMPANY TO BE MATERIALLY DIFFERENT FROM THE RESULTS, PERFORMANCE OR OTHER EXPECTATIONS IMPLIED BY THESE FORWARD-LOOKING STATEMENTS. THESE FACTORS INCLUDE, BUT ARE NOT LIMITED TO, THOSE DETAILED IN THE COMPANY'S PERIODIC FILINGS WITH THE SECURITIES AND EXCHANGE
COMMISSION.
Company Address
2017 High Ridge Road
Boynton Beach, FL 33426
Toll Free: 1-866-787-2396
Tel: 561-547-9499
Fax: 561-547-4025
Website: www.puradyn.com
Investor-relations@puradyn.com
Web Address:www.emergingmarketsllc.com
2017 High Ridge Road
Boynton Beach, FL 33426
Toll Free: 1-866-787-2396
Tel: 561-547-9499
Fax: 561-547-4025
Website: www.puradyn.com
Investor-relations@puradyn.com
Web Address:www.emergingmarketsllc.com
Contact Us:(321) 206-6682
126 S. Bumby Ave, Suite A
Orlando, FL 32803
Disclaimer
Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below:
Disclaimer
Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below:
EMC has a October 1, 2008 agreement with Puradyn, Inc. ("PFTI") to provide various services to PFTI for a twelve (12) month period. The agreement may be renewed for additional six (12) month periods ("Renewal Term"), unless EMC or PFTI provide written notice of termination to the other party. The terms of the agreement provide that PFTI will pay EMC the following compensation for its services: The sum of 300,000 rule 144 shares and 175,000 cashless warrants at a strike price of $0.75 and 175,000 warrants with a strike price of $1.25.to date nothing has been paid to EMC have been paid to EMC.
Wednesday, March 11, 2009
Omega Commercial Finance Signs Definitive Agreement to Acquire Sterling Mine Commercial Development Project
(OTCBB: OCFN)
Released Wednesday March 11, 8:00 am ET
(New York Commercial Real Estate Project Valued at $7,500,000)
MIAMI, March 11 /PRNewswire-FirstCall/ -- Omega Commercial Finance Corporation (OTC Bulletin Board: OCFN - News) is pleased to announce the signing of a Definitive Agreement to acquire, through a share exchange agreement, the Sterling Mine commercial real estate project located in Tuxedo Park, NY.
As previously announced, the Sterling Mine commercial real estate project is comprised of 30,654 sq. ft. of office and retail space located on 4.8 acres of prime real estate in Tuxedo Park, NY. The project is currently close to 75% complete and will be primarily comprised of retail space with adjoining office facilities. As of this date, Omega has been furnished with executed letters of intent that include 5 year occupancy terms by a local leasing agent. These agreements currently represent an occupancy rate of 84% upon completion of the project.
Tuxedo Park, NY. is known as a highly coveted community located approximately 35 minutes outside of New York City. The project location is strategically placed between commuter railway stations servicing the area and constant recreational traffic seeking the immensely popular facilities at Greenwood Lake, which hosts some of the Hudson Valley's most extraordinary natural wonders and attractions. Situated on the cusp of New York and New Jersey, the area evidences a median residential sales price of $315,000 which is the fifth highest residential market in the State of New York. While overall growth in the U.S. housing market has become stagnant, there is still ongoing residential development in Tuxedo Park, which attests to the continued growth of that area.
Jon S. Cummings IV, CEO stated, "We are very pleased with the signing of a Definitive Agreement for this project. We have established a specific niche in the commercial real estate market which has enabled us to expand our real estate holdings and increase our book value which currently sits at 30 cents per share before any pro-forma calculations. We are confident that this recent addition will be an excellent addition to our existing portfolio of projects."
Safe Harbor
This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Omega Commercial Finance Corp., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Omega Commercial Finance Corp.'s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in Omega Commercial Finance Corp. filings with the Securities and Exchange Commission.
CONTACT: Omega Commercial Finance Corporation
Investor Relations Dept.
Joseph Vazquez,
305-677-0306
__________________________________________________
MyMetics (OTCBB: MYMX)
Mymetics Corporation Acquires Virosome Biologicals B.V.
Released on Monday March 9, 9:56 am ET
This Acquisition Advances Mymetics' Corporate Strategy to Expand Its Vaccine Portfolio and Enhances Mymetics' Implementation of the Virosome Delivery Technology
NYON, Switzerland, March 9, 2009 (GLOBE NEWSWIRE) -- Mymetics Corporation (http://www.mymetics.com/) (OTC BB:MYMX.OB - News) announced today that it has signed a Share Purchase Agreement to acquire 100% of Bestewil Holding B.V., parent company of Virosome Biologicals B.V., from Norwood Immunology Limited (LSE:NIM.L - News) for cash and considerations.
Virosome Biologicals B.V. is engaged in the development of a proprietary vaccine delivery platform (virosome) as well as intranasal influenza and RSV vaccines. Under the terms of the Share Purchase Agreement, Antonius Stegmann, co-founder and CSO of Virosome Biologicals B.V, will remain CSO of Virosome Biologicals B.V.
The acquisition of Virosome Biologicals will expand Mymetics' current portfolio of vaccines which includes an HIV/AIDS early stage preventative vaccine in a Phase I Human Clinical trial in Belgium, and a Malaria vaccine currently in a Phase Ib Human Clinical trial in Tanzania. The acquisition brings two collaborations, an Influenza vaccine in a Phase II Human Clinical trial in collaboration with the Solvay Group (NYSE Euronext SOLB.BE), and in collaboration with MedImmune, a Respiratory Syncytial Virus (RSV) vaccine under pre-clinical testing used to treat a major cause of respiratory illness in young children, as well as Bestewil's Herpes Simplex Virus development, for a total pipeline of three vaccine candidates.
The closing will take place on April 1, 2009. The purchase price of EUR7.5 million (US$9.4 million) includes cash of EUR5 million, a secured 36 month 5% convertible and redeemable note of EUR2.5 million, as well as options with a value of approximately US$9.6 million. Conversion will be at the lesser of US$0.80 or the issue price of the shares of common stock that the Corporation intends to issue after the closing date for the purpose of raising the necessary funds to repay the bridge loan. Further consideration to be paid after completion of the Share Purchase Agreement includes: * A payment of up to EUR2.8 million in cash in the event of a license agreement being signed with a third party to access Bestewil intellectual property and know how in the field of RSV (Respiratory Syncytial Virus) ("RSV Licence:), * A payment of up to EUR3 million in cash should Solvay Pharmaceuticals B.V., a member of the Solvay Group (2006 sales US$3 billion), commence a Phase III clinical trial for its intranasal influenza vaccine, * A payment of 50% of Mymetics net royalties received from a RSV License, payable in cash to Norwood, * A 25% share of any net amounts received by Mymetics from a third party HSV (Herpes Simplex Virus) License based upon Bestewil intellectual property payable in cash.
Further details may be found in the Share Purchase Agreement incorporated in the company's Form 8-K filed with the Securities & Exchange Commission on March 9, 2009.
``This second acquisition fits into our corporate strategy; it increases our vaccine portfolio from two to three vaccines, it enhances the virosome delivery methodology, and it strengthens our research and development team,'' stated Christian Rochet, CEO, Mymetics Corp. ``The enlarged company will have increased research capabilities, an expanded intellectual property portfolio and a strong set of clinical trials in the field of immunology,'' continued Christian Rochet.
About Virosome Biologicals B.V.
Virosome Biologicals B.V., located in Leiden, Netherlands is focused on the development of virosome based vaccines. The Solvay influenza vaccine using a Virosome Biologicals adjuvant is currently in Phase II Human Clinical trials utilising Virosome Biologicals' virosome adjuvant.
On December 5th 2008 Virosome Biologicals B.V. signed a six month exclusive evaluation agreement for their virosome vaccine technology with MedImmune, an AstraZeneca subsidiary and recognized leader in vaccine research and development. Virosome Biologicals B.V. agreed to an exclusive six month collaborative research programme with MedImmune in exchange for an exclusivity fee and the reimbursement of certain costs associated with identified MedImmune vaccine candidates and the Virosome Biologicals B.V.'s virosome technology.
Virosome Biologicals have also developed a proprietary method of producing virosomes that maintain an excellent membrane fusion activity, a key component in the initial stimulation of the immune system. Virosome Biologicals' adjuvanted virosome technology is licensed to Solvay for the development of intranasal influenza vaccines, with milestones and royalties payable to Virosome Biologicals as the clinical development and commercialisation progresses. Solvay is responsible for clinical trials as well as the development and commercialisation of the vaccine and has successfully concluded a Phase I Human Clinical trial thus triggering a milestone payment to Virosome Biologicals. The vaccine was found to be safe and well tolerated. Solvay is continuing to test the vaccine in Phase II Human Clinical trials.
About Mymetics In February 2009 Mymetics announced the success of its pre-clinical HIV/AIDS viral challenge. The proven success of their vaccine in primates could not have been more compelling: the vaccinated group either proved resistant to the virus or remained at a non detectable level, whereas the non-vaccinated animals were completely infected. This success further prompted Mymetics to apply to the competent European regulatory authority to authorize the commencement of the Phase I Human Clinical Trials. Approval was granted in December 2008.
Mymetics Malaria vaccine has completed a first round of Human Clinical trial Phases I and II on adults in Switzerland and in the U.K., for testing of an initial two-antigen formulation. A Phase 1b clinical trial has been launched in Tanzania to extend the protocol to children and teenagers in a naturally endemic area with results expected in Q3 2009. A new cycle of Phase I and II Clinical trials with five antigens is scheduled thereafter in Q1 2010.
The Mymetics Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5478
Safe Harbor Forward-Looking Statements
Statements contained in this release that are not strictly historical are ``forward-looking statements.'' Such forward-looking statements are sometimes identified by words such as ``intends,'' ``anticipates,'' ``believes,'' ``expects'' and ``hopes.'' The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
Safe Harbor This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Omega Commercial Finance Corp., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Omega Commercial Finance Corp.'s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in Omega Commercial Finance Corp. filings with the Securities and Exchange Commission.
EMC reserves the right to buy and sell in the securities profiled in our emails. Never invest in small cap security unless you can afford to lose your entire investment.
Disclaimer
Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below:
EMC has a March 3, 2009 agreement with Small Cap Voice to provide various services to OCFN for a twelve (1) month period. The agreement may be renewed for additional one (1) month periods ("Renewal Term"), unless EMC or SCV provide written notice of termination to the other party. The terms of the agreement provide that Small Cap Voice will pay EMC the following compensation for its services: 240,000 free trading shares. EMC intends to sell these shares. This could have a negative impact on the market.
EMC has a August 20th,2008 with SIDC SA to provide various IR services on behalf of MYMX mymedics. The terms of this agreement provide that EMC be paid 200,000 free trading and intends to recive 400,00 restricted shares for 120 days of services. To date EMC has recived 200,000 shares
Visit http://www.emergingmarketsllc.com/ for full disclaimer
Monday, March 9, 2009
Emerging Markets Consulting is a syndicate of investor relations consultants representing years of experience. Our network consists of stock brokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.The Emerging Markets Consulting model employs a variety of conventional and non-conventional programs and tools to communicate your company's story and increase your exposure in the micro and small-cap equity markets. These include:
Advanced Telemarketing
One-on-one Meetings
Conference Calls
City-Wide Conferences
E-mail Communications
Web Casts
Direct-Mail Marketing
We are selective in the companies that we choose to represent. We look for companies with compelling stories, strong growth potential, near-term profitability, and superior management. We have built our reputation representing quality, undervalued companies, while providing extraordinary service and delivering concrete, measurable results.
Advanced Telemarketing
One-on-one Meetings
Conference Calls
City-Wide Conferences
E-mail Communications
Web Casts
Direct-Mail Marketing
We are selective in the companies that we choose to represent. We look for companies with compelling stories, strong growth potential, near-term profitability, and superior management. We have built our reputation representing quality, undervalued companies, while providing extraordinary service and delivering concrete, measurable results.
Subscribe to:
Posts (Atom)